The Regulation on the Withdrawal of Medicinal Products for Human Use and Foods for Special Medical Purposes (“Regulation“) was published in the Official Gazette, and entered into force on 23 October 2024. With the Regulation coming into force, the Withdrawal Regulation published in the Official Gazette on 19 November 2015 (“Previous Regulation”) was abolished. Unlike the Previous Regulation, the scope of the Regulation merely includes medicinal products for human use and active substances used in the production of medicinal products for human use as well as matters regarding the withdrawal activities, production, placing and keeping on the market medicinal products for human use.
The Regulation introduces detailed provisions as per which the Turkish Medicines and Medical Devices Agency (“TMMDA”) shall evaluate faulty or suspicious products, request information from the marketing authorization holder where necessary, conclude on withdrawal, conduct relevant proceedings in the Drug Tracking System (İTS), ensure oversight of the processes, halt the production of faulty products and take the necessary measures to prevent incompliance, and conduct necessary checks before re-introducing products to the market. In this regard, a “Withdrawal Evaluation Commission” has been introduced along with a number of new practices. Ultimately, the aim is to adopt an effective and integrated system for the withdrawal of medicinal products for human use and foods for special medical purposes through putting in place comprehensive regulations and sanctions.
Share
Related persons
You can contact us for detailed information.

Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
20 May 2025
The Regional Court of Appeal Reaffirmed the Application of the New York Convention and the Prohibition of Révision au Fond in Enforcement Proceedings
In its decision dated 21 April 2025, the 9th Civil Chamber of the Adana Regional Court of Appeal (“Regional Court of Appeal”) ruled that,…
14 May 2025
The Future of Hydrogen Energy in Türkiye
Hydrogen energy is emerging as a key pillar in the global transition towards renewable energy sources. With its versatile applications in…
14 May 2025
Turkish IPOs in Istanbul, London and the United States – Key Issues for Market Participants
The Turkish IPO market has continued its robust growth in recent years, with 179 companies completing IPOs between 2021 and 2024, raising…
29 April 2025
Regulation on Private Health Institutions Providing Outpatient Diagnosis and Treatment
The Regulation on Private Health Institutions Providing Outpatient Diagnosis and Treatment Services (“Regulation“) was published in the…
29 April 2025
The Turkish Regional Court of Appeal in Ankara, 31st Civil Chamber, Confirmed That Preliminary Attachment Can Be Imposed on the Respondent’s Assets Pending Enforcement Proceedings
In proceedings for the enforcement of foreign arbitral awards, it is crucial to secure the enforcement of the award, in other words, to…
21 April 2025
New Communiqué on Green Asset Ratio of Banks Published
The Communiqué on the Calculation of Green Asset Ratio of Banks (the “Communiqué”) was published in the Official Gazette dated 11 April…